<VariationArchive RecordType="classified" VariationID="1333313" VariationName="NM_002150.3(HPD):c.463del (p.Gln155fs)" VariationType="Deletion" Accession="VCV001333313" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-01-15" MostRecentSubmission="2022-01-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1324088" VariationID="1333313">
      <GeneList>
        <Gene Symbol="HPD" FullName="4-hydroxyphenylpyruvate dioxygenase" GeneID="3242" HGNC_ID="HGNC:5147" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="121839527" stop="121888611" display_start="121839527" display_stop="121888611" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="122277432" stop="122326516" display_start="122277432" display_stop="122326516" Strand="-" />
          </Location>
          <OMIM>609695</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002150.3(HPD):c.463del (p.Gln155fs)</Name>
      <CanonicalSPDI>NC_000012.12:121849741:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="121849742" stop="121849742" display_start="121849742" display_stop="121849742" variantLength="1" positionVCF="121849741" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="122287648" stop="122287648" display_start="122287648" display_stop="122287648" variantLength="1" positionVCF="122287647" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q116fs</ProteinChange>
      <ProteinChange>Q155fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.122287649del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.122287649del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.121849743del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.121849743del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016461.1" sequenceAccession="NG_016461" sequenceVersion="1" change="g.43870del">
            <Expression>NG_016461.1:g.43870del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171993.2" sequenceAccession="NM_001171993" sequenceVersion="2" change="c.346del">
            <Expression>NM_001171993.2:c.346del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165464.1" sequenceAccession="NP_001165464" sequenceVersion="1" change="p.Gln116fs">
            <Expression>NP_001165464.1:p.Gln116fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002150.3" sequenceAccession="NM_002150" sequenceVersion="3" change="c.463del" MANESelect="true">
            <Expression>NM_002150.3:c.463del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002141.2" sequenceAccession="NP_002141" sequenceVersion="2" change="p.Gln155fs">
            <Expression>NP_002141.2:p.Gln155fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2137619413" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002150.3(HPD):c.463del (p.Gln155fs) AND Tyrosinemia type III" Accession="RCV001808001" Version="1">
        <ClassifiedConditionList TraitSetID="403">
          <ClassifiedCondition DB="MedGen" ID="C0268623">Tyrosinemia type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-01-15" MostRecentSubmission="2022-01-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="403" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15918" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tyrosinemia type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinemia type III</ElementValue>
                <XRef ID="MONDO:0010162" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">4-alpha hydroxyphenylpyruvic acid oxidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">4-alpha hydroxyphenylpyruvate dioxygenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">4-Hydroxyphenylpyruvate dioxygenase deficiency</ElementValue>
                <XRef ID="Tyrosinemia+type+3/7283" DB="Genetic Alliance" />
                <XRef ID="413356003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">4-HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="276710" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TYRSN3</ElementValue>
                <XRef Type="MIM" ID="276710" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10332" />
                <XRef ID="10332" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tyrosine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased Tyrosine, Tyrosinemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tryosine-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Tyrosine Elevated, Succinylacetone Normal, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tyrosine-Normal-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Tyrosine Normal/Elevated, Succinylacetone Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="69723" DB="Orphanet" />
              <XRef ID="C0268623" DB="MedGen" />
              <XRef ID="MONDO:0010162" DB="MONDO" />
              <XRef Type="MIM" ID="276710" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4031984" SubmissionDate="2022-01-11" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="12-122287647-TG-T" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002058351" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Each parent is heterozygous for the variant (PM3_P, 3billion dataset). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0100021" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002150.3:c.463del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276710" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918354</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4031984" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100021" MappingRef="HP">
        <MedGen CUI="C0007789" Name="Cerebral palsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4031984" TraitType="Disease" MappingType="XRef" MappingValue="276710" MappingRef="OMIM">
        <MedGen CUI="C0268623" Name="Tyrosinemia type III" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

